Recombinant botulinum neurotoxin serotype A1 in vivo characterization.
Périer C, Martin V, Cornet S, Favre-Guilmard C, Rocher MN, Bindler J, Wagner S, Andriambeloson E, Rudkin B, Marty R, Vignaud A, Beard M, Lezmi S, Kalinichev M.
Périer C, et al. Among authors: martin v.
Pharmacol Res Perspect. 2021 Oct;9(5):e00857. doi: 10.1002/prp2.857.
Pharmacol Res Perspect. 2021.
PMID: 34632725
Free PMC article.